Nitric oxide modulates mitochondrial respiration in failing human heart.

Background-Our objective for this study was to investigate whether nitric oxide (NO) modulates tissue respiration in the failing human myocardium. Methods and Results-Left ventricular free wall and right ventricular tissue samples were taken from 14 failing explanted human hearts at the time of transplantation. Tissue oxygen consumption was measured with a Clark-type oxygen electrode in an airtight stirred bath containing Krebs solution buffered with HEPES at 37 degrees C (pH 7.4). Rate of decrease in oxygen concentration was expressed as a percentage of the baseline, and results of the highest dose are indicated. Bradykinin (10(-4) mol/L, -21+/-5%), amlodipine (10(-5) mol/L, -14+/-5%), the ACE inhibitor ramiprilat (10(-4) mol/L, -21+/-2%), and the neutral endopeptidase inhibitor thiorphan (10(-4) mol/L, -16+/-5%) all caused concentration-dependent decreases in tissue oxygen consumption. Responses to bradykinin (-2+/-6%), amlodipine (-2+/-4%), ramiprilat (-5+/-6%), and thiorphan (-4+/-7%) were significantly attenuated after NO synthase blockade with N-nitro-L-arginine methyl ester (10(-4) mol/L; all P<0.05). NO-releasing compounds S-nitroso-N-acetyl-penicillamine (10(-4) mol/L, -34+/-5%) and nitroglycerin (10(-4) mol/L, -21+/-5%), also decreased tissue oxygen consumption in a concentration-dependent manner. However, the reduction in tissue oxygen consumption in response to S-nitroso-N-acetyl-penicillamine (-35+/-7%) or nitroglycerin (-16+/-5%) was not significantly affected by N-nitro-L-arginine methyl ester. Conclusions-These results indicate that the modulation of oxygen consumption by both endogenous and exogenous NO is preserved in the failing human myocardium and that the inhibition of kinin degradation plays an important role in the regulation of mitochondrial respiration.

[1]  O. Carretero,et al.  Role of Nitric Oxide in the Control of Cardiac Oxygen Consumption in B2-Kinin Receptor Knockout Mice , 1999 .

[2]  S. Dhein,et al.  Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent. , 1999, Circulation.

[3]  P. Mcconnell,et al.  Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. , 1999, Circulation research.

[4]  F. Recchia,et al.  Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.

[5]  M. Oz,et al.  Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. , 1998, The Journal of thoracic and cardiovascular surgery.

[6]  X. Xu,et al.  Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. , 1998, Circulation research.

[7]  K. Swedberg,et al.  Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure , 1998, The Lancet.

[8]  X. Xu,et al.  Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism. , 1998, Journal of cardiovascular pharmacology.

[9]  M. Fournié-Zaluski,et al.  Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels. , 1998, European journal of pharmacology.

[10]  M. Oz,et al.  Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts. , 1997, The American journal of cardiology.

[11]  X. Xu,et al.  ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. , 1997, Circulation.

[12]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[13]  X. Xu,et al.  Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. , 1996, Circulation research.

[14]  G. Zhao,et al.  Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. , 1996, Circulation research.

[15]  C. Marboe,et al.  Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. , 1996, Circulation.

[16]  J. Abrams,et al.  Beneficial actions of nitrates in cardiovascular disease. , 1996, The American journal of cardiology.

[17]  T. Hintze,et al.  Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. , 1995, Circulation.

[18]  A. Sanbe,et al.  Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. , 1995, Journal of molecular and cellular cardiology.

[19]  B. Griffith,et al.  Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. , 1995, Chest.

[20]  M C Oz,et al.  Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. , 1995, Circulation.

[21]  G. Zhao,et al.  Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. , 1994, Circulation research.

[22]  S. Moncada,et al.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide , 1994, FEBS letters.

[23]  M. J. Winn,et al.  Canine hindlimb blood flow and O2 uptake after inhibition of EDRF/NO synthesis. , 1994, Journal of applied physiology.

[24]  S. Zierz,et al.  Myocardial respiratory chain enzyme activities in idiopathic dilated cardiomyopathy, and comparison with those in atherosclerotic coronary artery disease and valvular aortic stenosis. , 1993, The American journal of cardiology.

[25]  M. Lesch,et al.  Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. , 1992, Journal of molecular and cellular cardiology.

[26]  A. Jardine,et al.  Increased circulating atrial natriuretic factor concentrations in patients with chronic heart failure after inhibition of neutral endopeptidase: effects on diastolic function , 1992, British heart journal.

[27]  S. Turcaud,et al.  A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. , 1992, Molecular pharmacology.

[28]  D. Wallace,et al.  Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. , 1991, JAMA.

[29]  T. Ozawa,et al.  Cardiomyopathy with mitochondrial DNA mutations. , 1991, American Heart Journal.

[30]  A. Abundis,et al.  Effect of nitroglycerine on rat myocardium oxygen consumption, determined by the manometric Warburg procedure , 1991 .

[31]  K. Ohno,et al.  Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy. , 1990, Biochemical and biophysical research communications.

[32]  J. Lancaster,et al.  EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[34]  J. Drapier,et al.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. , 1986, The Journal of clinical investigation.

[35]  W. Parmley,et al.  Energy levels at systole vs. diastole in normal hamster hearts vs. myopathic hamster hearts. , 1983, Circulation research.

[36]  J. Lancaster,et al.  Nitrite inhibition of Clostridium botulinum: electron spin resonance detection of iron-nitric oxide complexes. , 1983, Science.

[37]  A. Lehninger,et al.  Sites of inhibition of mitochondrial electron transport in macrophage- injured neoplastic cells , 1982, The Journal of cell biology.

[38]  A. Gerdes,et al.  Regional differences in capillary density and myocyte size in the normal human heart , 1982, The Anatomical record.

[39]  R. Magorien,et al.  Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. , 1980, The Journal of pharmacology and experimental therapeutics.

[40]  J. Allen,et al.  Oxidative phosphorylation and respiration by mitochondria from normal, hypertrophied and failing rat hearts. , 1977, Journal of molecular and cellular cardiology.

[41]  A. Schwartz,et al.  Some biochemical studies on subcellular systems isolated from fresh recipient human cardiac tissue obtained during transplantation. , 1971, The American journal of cardiology.

[42]  E. Bajusz,et al.  Oxidative phosphorylation and calcium transport of mitochondria isolated from cardiomyopathic hamster hearts. , 1970, Journal of molecular and cellular cardiology.

[43]  E. Braunwald,et al.  Normal Oxidative Phosphorylation in Mitochondria from the Failing Heart , 1967 .

[44]  C. J. Carr,et al.  Alkyl nitrites. XV. The effect of nitrites and nitrates on the oxygen uptake of arterial tissue. , 1951, The Journal of pharmacology and experimental therapeutics.

[45]  Eter,et al.  EFFECT OF AMLODIPINE ON MORBIDITY AND MORTALITY IN SEVERE CHRONIC HEART FAILURE , 2000 .

[46]  A. Richards,et al.  Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. , 1998, Journal of cardiovascular pharmacology.

[47]  K. Pritchard,et al.  Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. , 1996, Circulation research.

[48]  K. Grønseth,et al.  Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. , 1996, The American journal of cardiology.

[49]  A. Rangel Abundis,et al.  Effect of nitroglycerin on rat myocardium oxygen consumption, determined by the manometric Warburg procedure. , 1991, Archivos de investigacion medica.

[50]  C. Chidsey,et al.  Biochemical studies of energy production in the failing human heart. , 1966, The Journal of clinical investigation.